Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
American Journal of Surgery|May 30, 2001
Management of medically refractory ascitesE E Zervos, A S Rosemurgy
Breast Cancer (Tokyo, Japan)|October 13, 2000
Lymphatic mapping for breast cancer: experience at The Ohio State UniversityE E Zervos, W E Burak
The Journal of Surgical Research|January 16, 1999
Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancerE E Zervos, A E Shafii, A S Rosemurgy
The Journal of Surgical Research|April 16, 1998
Immediate and long-term portal hemodynamic consequences of small-diameter H-graft portacaval shuntE E Zervos, S E Goode, A S Rosemurgy
The American Surgeon|February 11, 1998
Small-diameter H-graft portacaval shunt reduces portal flow yet maintains effective hepatic blood flowE E Zervos, S E Goode, A S Rosemurgy
Cancer Research|June 24, 2000
Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancerM Haq, A Shafii, E E Zervos, et al.
International Journal of Surgical Investigation|December 4, 2001
In vitro and in vivo matrix metalloproteinase production by pancreatic cancer cells and by distant organsM Haq, A E Shaeii, E E Zervos, et al.
The Journal of Surgical Research|June 8, 1999
Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitroE E Zervos, A E Shafii, M Haq, et al.
Obesity Surgery|August 1, 1997
Bariatric surgery and multiple personality disorder: complexities and nuances of careM Bloomston, E E Zervos, P S Powers, et al.
The American Surgeon|February 1, 1997
Peritoneovenous shunts in patients with intractable ascites: palliation at what price?E E Zervos, J McCormick, S E Goode, et al.
Pageof 3